
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Period Ending | 2021-04-30 | 2022-04-30 | 2023-04-30 | 2024-04-30 | 2025-04-30 | |
---|---|---|---|---|---|---|
Revenue | $1.7B | $2.4B | $2.3B | $2B | $2.1B | |
Revenue Growth (YoY) | 1.78% | 35.9% | -0.31% | -12.87% | 3.04% | |
Cost of Revenues | $994M | $1.5B | $1.4B | $1.2B | $1.2B | |
Gross Profit | $740.3M | $879.8M | $964.7M | $881.7M | $926.4M | |
Gross Profit Margin | 42.69% | 37.33% | 41.06% | 43.07% | 43.92% | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $603.5M | $673M | $753.3M | $730.9M | $770M | |
Other Inc / (Exp) | $9.5M | -$1.7M | -$11.8M | -$71K | -$23.6M | |
Operating Expenses | $603.5M | $673M | $753.3M | $730.9M | $770M | |
Operating Income | $136.7M | $206.8M | $211.4M | $150.8M | $156.4M | |
Net Interest Expenses | $289K | -- | -- | -- | -- | |
EBT. Incl. Unusual Items | $145.9M | $205.5M | $205.8M | $165.8M | $147.1M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $38.4M | $53.2M | $53.8M | $41.1M | $46.2M | |
Net Income to Company | $107.5M | $152.3M | $151.9M | $124.6M | $101M | |
Minority Interest in Earnings | -$1.1M | -$2.3M | -$1.3M | -$2M | -$1.4M | |
Net Income to Common Excl Extra Items | $106.5M | $150M | $150.7M | $122.6M | $99.6M | |
Basic EPS (Cont. Ops) | $2.31 | $3.41 | $3.49 | $2.86 | $2.39 | |
Diluted EPS (Cont. Ops) | $2.30 | $3.39 | $3.48 | $2.83 | $2.35 | |
Weighted Average Basic Share | $46M | $44M | $43.1M | $42.9M | $41.6M | |
Weighted Average Diluted Share | $46.4M | $44.3M | $43.2M | $43.3M | $42.3M | |
EBITDA | $245.9M | $319.1M | $323M | $290.9M | $271.3M | |
EBIT | $147.3M | $206.4M | $206.3M | $166.2M | $147.7M | |
Revenue (Reported) | $1.7B | $2.4B | $2.3B | $2B | $2.1B | |
Operating Income (Reported) | $136.7M | $206.8M | $211.4M | $150.8M | $156.4M | |
Operating Income (Adjusted) | $147.3M | $206.4M | $206.3M | $166.2M | $147.7M |
Period Ending | 2021-04-30 | 2022-04-30 | 2023-04-30 | 2024-04-30 | 2025-04-30 | |
---|---|---|---|---|---|---|
Revenue | $519.5M | $684.6M | $561.3M | $553.5M | $570.9M | |
Revenue Growth (YoY) | 41.44% | 31.78% | -18.01% | -1.38% | 3.13% | |
Cost of Revenues | $297.4M | $449.5M | $312.6M | $313.5M | $319.8M | |
Gross Profit | $222.1M | $235.1M | $248.6M | $240.1M | $251.1M | |
Gross Profit Margin | 42.75% | 34.34% | 44.3% | 43.37% | 43.98% | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $172M | $156.3M | $194.6M | $190M | $201M | |
Other Inc / (Exp) | $1.5M | -$1.2M | -$11M | -$92K | -$21.2M | |
Operating Expenses | $172M | $156.3M | $194.6M | $190M | $201M | |
Operating Income | $50.1M | $78.8M | $54.1M | $50.1M | $50.1M | |
Net Interest Expenses | $88K | -- | -- | -- | -- | |
EBT. Incl. Unusual Items | $51.4M | $77.7M | $46M | $54.1M | $32M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $13.5M | $20.1M | $11.4M | $13.8M | $16.7M | |
Net Income to Company | $38M | $57.6M | $34.6M | $40.3M | $15.4M | |
Minority Interest in Earnings | -$461K | -$154K | -$272K | -$1M | -$419K | |
Net Income to Common Excl Extra Items | $37.5M | $57.5M | $34.4M | $39.3M | $14.9M | |
Basic EPS (Cont. Ops) | $0.82 | $1.32 | $0.79 | $0.92 | $0.36 | |
Diluted EPS (Cont. Ops) | $0.81 | $1.32 | $0.78 | $0.91 | $0.36 | |
Weighted Average Basic Share | $45.7M | $43.1M | $43.3M | $42.5M | $41.2M | |
Weighted Average Diluted Share | $46.2M | $43.3M | $43.6M | $43.1M | $42.2M | |
EBITDA | $76.8M | $109.5M | $76M | $85.8M | $59.2M | |
EBIT | $51.7M | $77.9M | $46.2M | $54.3M | $32.2M | |
Revenue (Reported) | $519.5M | $684.6M | $561.3M | $553.5M | $570.9M | |
Operating Income (Reported) | $50.1M | $78.8M | $54.1M | $50.1M | $50.1M | |
Operating Income (Adjusted) | $51.7M | $77.9M | $46.2M | $54.3M | $32.2M |
Period Ending | 2021-04-30 | 2022-04-30 | 2023-04-30 | 2024-04-30 | 2025-04-30 | |
---|---|---|---|---|---|---|
Revenue | $1.7B | $2.4B | $2.3B | $2B | $2.1B | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $994M | $1.5B | $1.4B | $1.2B | $1.2B | |
Gross Profit | $740.3M | $879.8M | $964.7M | $881.7M | $926.4M | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $603.5M | $673M | $753.3M | $730.9M | $770M | |
Other Inc / (Exp) | $9.5M | -$1.7M | -$11.8M | -$71K | -$23.6M | |
Operating Expenses | $603.5M | $673M | $753.3M | $730.9M | $770M | |
Operating Income | $136.7M | $206.8M | $211.4M | $150.8M | $156.4M | |
Net Interest Expenses | $289K | -- | -- | -- | -- | |
EBT. Incl. Unusual Items | $145.9M | $205.5M | $205.8M | $165.8M | $147.1M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $38.4M | $53.2M | $53.8M | $41.1M | $46.2M | |
Net Income to Company | $107.5M | $152.3M | $151.9M | $124.6M | $101M | |
Minority Interest in Earnings | -$1.1M | -$2.3M | -$1.3M | -$2M | -$1.4M | |
Net Income to Common Excl Extra Items | $106.5M | $150M | $150.7M | $122.6M | $99.6M | |
Basic EPS (Cont. Ops) | $2.31 | $3.40 | $3.49 | $2.86 | $2.39 | |
Diluted EPS (Cont. Ops) | $2.28 | $3.40 | $3.48 | $2.83 | $2.36 | |
Weighted Average Basic Share | ||||||
Weighted Average Diluted Share | ||||||
EBITDA | $245.9M | $319.1M | $323M | $290.9M | $271.3M | |
EBIT | $147.3M | $206.4M | $206.3M | $166.2M | $147.7M | |
Revenue (Reported) | $1.7B | $2.4B | $2.3B | $2B | $2.1B | |
Operating Income (Reported) | $136.7M | $206.8M | $211.4M | $150.8M | $156.4M | |
Operating Income (Adjusted) | $147.3M | $206.4M | $206.3M | $166.2M | $147.7M |
Period Ending | 2022-04-30 | 2023-04-30 | 2024-04-30 | 2025-04-30 | 2026-04-30 | |
---|---|---|---|---|---|---|
Revenue | $2.4B | $2.3B | $2B | $2.1B | -- | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $1.5B | $1.4B | $1.2B | $1.2B | -- | |
Gross Profit | $879.8M | $964.7M | $881.7M | $926.4M | -- | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $673M | $753.3M | $730.9M | $770M | -- | |
Other Inc / (Exp) | -$1.7M | -$11.8M | -$71K | -$23.6M | -- | |
Operating Expenses | $673M | $753.3M | $730.9M | $770M | -- | |
Operating Income | $206.8M | $211.4M | $150.8M | $156.4M | -- | |
Net Interest Expenses | $330K | -- | -- | -- | -- | |
EBT. Incl. Unusual Items | $205.5M | $205.8M | $165.8M | $147.1M | -- | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $53.2M | $53.8M | $41.1M | $46.2M | -- | |
Net Income to Company | $152.3M | $151.9M | $124.6M | $101M | -- | |
Minority Interest in Earnings | -$2.3M | -$1.3M | -$2M | -$1.4M | -- | |
Net Income to Common Excl Extra Items | $150M | $150.7M | $122.6M | $99.6M | -- | |
Basic EPS (Cont. Ops) | $3.40 | $3.49 | $2.86 | $2.39 | -- | |
Diluted EPS (Cont. Ops) | $3.40 | $3.48 | $2.83 | $2.36 | -- | |
Weighted Average Basic Share | $176.1M | $172.6M | $171.5M | $166.4M | -- | |
Weighted Average Diluted Share | $177.1M | $173.1M | $173M | $169.1M | -- | |
EBITDA | $319.1M | $323M | $290.9M | $271.3M | -- | |
EBIT | $206.4M | $206.3M | $166.2M | $147.7M | -- | |
Revenue (Reported) | $2.4B | $2.3B | $2B | $2.1B | -- | |
Operating Income (Reported) | $206.8M | $211.4M | $150.8M | $156.4M | -- | |
Operating Income (Adjusted) | $206.4M | $206.3M | $166.2M | $147.7M | -- |
Period Ending | 2021-04-30 | 2022-04-30 | 2023-04-30 | 2024-04-30 | 2025-04-30 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $391.2M | $245.6M | $343.4M | $341.1M | $328.4M | |
Short Term Investments | -- | -- | -- | -- | -- | |
Accounts Receivable, Net | $139.3M | $183.7M | $125.5M | $139.2M | $139.5M | |
Inventory | $226.1M | $303.2M | $276.3M | $263.2M | $255.3M | |
Prepaid Expenses | -- | -- | -- | -- | -- | |
Other Current Assets | $166M | $216M | $106.1M | $93.3M | $82.4M | |
Total Current Assets | $926.2M | $951.8M | $854.6M | $836.8M | $805.7M | |
Property Plant And Equipment | $563M | $658.9M | $694.8M | $744.7M | $792.1M | |
Long-Term Investments | -- | -- | -- | -- | -- | |
Goodwill | $175.8M | $194.6M | $205M | $214.5M | $205.6M | |
Other Intangibles | $30.4M | $34M | $39.4M | $47.3M | $51.2M | |
Other Long-Term Assets | $79M | $82.2M | $63.5M | $60M | $60.3M | |
Total Assets | $1.8B | $1.9B | $1.9B | $1.9B | $1.9B | |
Accounts Payable | $94.2M | $104M | $107.5M | $96.5M | $96M | |
Accrued Expenses | $77M | $78.8M | $83.2M | $81.5M | $87.7M | |
Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
Current Portion Of Capital Lease Obligations | $67.6M | $75.3M | $77.8M | $77M | $80.6M | |
Other Current Liabilities | $83.7M | $95.3M | $56.7M | $58M | $51.1M | |
Total Current Liabilities | $611.7M | $675.7M | $475.9M | $437.3M | $420.8M | |
Long-Term Debt | -- | -- | -- | -- | -- | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $1B | $1.1B | $914.2M | $900.1M | $890.2M | |
Common Stock | $45.4M | $43.1M | $43.3M | $42.4M | $41.2M | |
Other Common Equity Adj | -$1.5M | -$5.8M | -$5.5M | -$5.9M | -$3.6M | |
Common Equity | $773.5M | $810.7M | $941.8M | $1B | $1B | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | $8.6M | $8.9M | $10.3M | $10.3M | $11.4M | |
Total Equity | $782.1M | $819.6M | $952.1M | $1B | $1B | |
Total Liabilities and Equity | $1.8B | $1.9B | $1.9B | $1.9B | $1.9B | |
Cash and Short Terms | $391.2M | $245.6M | $343.4M | $341.1M | $328.4M | |
Total Debt | -- | -- | -- | -- | -- |
Period Ending | 2021-04-30 | 2022-04-30 | 2023-04-30 | 2024-04-30 | 2025-04-30 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $391.2M | $245.6M | $343.4M | $341.1M | $328.4M | |
Short Term Investments | -- | -- | -- | -- | -- | |
Accounts Receivable, Net | $139.3M | $183.7M | $125.5M | $139.2M | $139.5M | |
Inventory | $226.1M | $303.2M | $276.3M | $263.2M | $255.3M | |
Prepaid Expenses | -- | -- | -- | -- | -- | |
Other Current Assets | $166M | $216M | $106.1M | $93.3M | $82.4M | |
Total Current Assets | $926.2M | $951.8M | $854.6M | $836.8M | $805.7M | |
Property Plant And Equipment | $563M | $658.9M | $694.8M | $744.7M | $792.1M | |
Long-Term Investments | -- | -- | -- | -- | -- | |
Goodwill | $175.8M | $194.6M | $205M | $214.5M | $205.6M | |
Other Intangibles | $30.4M | $34M | $39.4M | $47.3M | $51.2M | |
Other Long-Term Assets | $79M | $82.2M | $63.5M | $60M | $60.3M | |
Total Assets | $1.8B | $1.9B | $1.9B | $1.9B | $1.9B | |
Accounts Payable | $94.2M | $104M | $107.5M | $96.5M | $96M | |
Accrued Expenses | $77M | $78.8M | $83.2M | $81.5M | $87.7M | |
Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
Current Portion Of Capital Lease Obligations | $67.6M | $75.3M | $77.8M | $77M | $80.6M | |
Other Current Liabilities | $83.7M | $95.3M | $56.7M | $58M | $51.1M | |
Total Current Liabilities | $611.7M | $675.7M | $475.9M | $437.3M | $420.8M | |
Long-Term Debt | -- | -- | -- | -- | -- | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $1B | $1.1B | $914.2M | $900.1M | $890.2M | |
Common Stock | $45.4M | $43.1M | $43.3M | $42.4M | $41.2M | |
Other Common Equity Adj | -$1.5M | -$5.8M | -$5.5M | -$5.9M | -$3.6M | |
Common Equity | -- | -- | -- | -- | -- | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | $8.6M | $8.9M | $10.3M | $10.3M | $11.4M | |
Total Equity | $782.1M | $819.6M | $952.1M | $1B | $1B | |
Total Liabilities and Equity | $1.8B | $1.9B | $1.9B | $1.9B | $1.9B | |
Cash and Short Terms | $391.2M | $245.6M | $343.4M | $341.1M | $328.4M | |
Total Debt | -- | -- | -- | -- | -- |
Period Ending | 2021-04-30 | 2022-04-30 | 2023-04-30 | 2024-04-30 | 2025-04-30 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $107.5M | $152.3M | $151.9M | $124.6M | $101M | |
Depreciation & Amoritzation | $98.6M | $112.7M | $116.7M | $124.7M | $123.6M | |
Stock-Based Compensation | $12.7M | $11.9M | $12.5M | $14.4M | $17.4M | |
Change in Accounts Receivable | -$38.3M | -$41.8M | $53.7M | -$16.8M | -$1.9M | |
Change in Inventories | -$40.7M | -$72M | $32.3M | $19.9M | $12.8M | |
Cash From Operations | $309.9M | $79M | $205.2M | $158.1M | $187.3M | |
Capital Expenditures | $38M | $76.6M | $68.8M | $53.6M | $74.3M | |
Cash Acquisitions | -$2M | -$26.3M | -$16.8M | -$39.4M | -$29.5M | |
Cash From Investing | -$40.7M | -$78.4M | -$70.1M | -$81.6M | -$98.4M | |
Dividends Paid (Ex Special Dividend) | -$16.5M | -$27.7M | -$29.9M | -$32.7M | -$35M | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | -- | -- | -- | -- | -- | |
Long-Term Debt Repaid | -$75.1M | -$121K | -$123K | -$489K | -$663K | |
Repurchase of Common Stock | -$44.2M | -$90.6M | -$5M | -$52.8M | -$77.9M | |
Other Financing Activities | -$14.3M | -$24.3M | -$5M | -$6.2M | -$1.4M | |
Cash From Financing | -$141.1M | -$144.6M | -$37.1M | -$81.2M | -$102.6M | |
Beginning Cash (CF) | $263.5M | $394.7M | $248.9M | $346.7M | $341.1M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $128.2M | -$143.9M | $97.9M | -$4.7M | -$13.7M | |
Ending Cash (CF) | $394.7M | $248.9M | $346.7M | $341.1M | $328.4M | |
Levered Free Cash Flow | $272M | $2.4M | $136.4M | $104.6M | $113M |
Period Ending | 2021-04-30 | 2022-04-30 | 2023-04-30 | 2024-04-30 | 2025-04-30 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $38M | $57.6M | $34.6M | $40.3M | $15.4M | |
Depreciation & Amoritzation | $25.1M | $31.6M | $29.8M | $31.5M | $27.1M | |
Stock-Based Compensation | $3.6M | $3M | $4M | $3.4M | $4M | |
Change in Accounts Receivable | -$9.6M | -$21.5M | $11.2M | -$21.1M | -$12.4M | |
Change in Inventories | -$14.3M | $11.1M | $27.8M | $13.9M | $34.5M | |
Cash From Operations | $60.1M | $33.8M | $78.1M | $52.8M | $62M | |
Capital Expenditures | $11.2M | $18M | $11.4M | $15.5M | $22.7M | |
Cash Acquisitions | -- | -$1.5M | -$5M | -$13.1M | -$4.8M | |
Cash From Investing | -$10.8M | -$1.3M | -$12.2M | -$27.5M | -$27.2M | |
Dividends Paid (Ex Special Dividend) | -$6.8M | -$7.1M | -$7.8M | -$8.5M | -$9.1M | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | -- | -- | -- | -- | -- | |
Long-Term Debt Repaid | -$30K | -$30K | -$31K | -$143K | -$221K | |
Repurchase of Common Stock | -$43.3M | -$15M | -- | -$12.8M | -$13.5M | |
Other Financing Activities | -- | -- | -- | -- | -- | |
Cash From Financing | -$47.4M | -$22.3M | -$3.2M | -$16.8M | -$21.4M | |
Beginning Cash (CF) | $393M | $240M | $284M | $333.2M | $314.6M | |
Foreign Exchange Rate Adjustment | -$176K | -$1.3M | -$82K | -$578K | $461K | |
Additions / Reductions | $1.9M | $10.2M | $62.7M | $8.5M | $13.4M | |
Ending Cash (CF) | $394.7M | $248.9M | $346.7M | $341.1M | $328.4M | |
Levered Free Cash Flow | $48.8M | $15.8M | $66.7M | $37.3M | $39.3M |
Period Ending | 2021-04-30 | 2022-04-30 | 2023-04-30 | 2024-04-30 | 2025-04-30 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $107.5M | $152.3M | $151.9M | $124.6M | $101M | |
Depreciation & Amoritzation | $98.6M | $112.7M | $116.7M | $124.7M | $123.6M | |
Stock-Based Compensation | $12.7M | $11.9M | $12.5M | $14.4M | $17.4M | |
Change in Accounts Receivable | -$38.3M | -$41.8M | $53.7M | -$16.8M | -$1.9M | |
Change in Inventories | -$40.7M | -$72M | $32.3M | $19.9M | $12.8M | |
Cash From Operations | $309.9M | $79M | $205.2M | $158.1M | $187.3M | |
Capital Expenditures | $38M | $76.6M | $68.8M | $53.6M | $74.3M | |
Cash Acquisitions | -$2M | -$26.3M | -$16.8M | -$39.4M | -$29.5M | |
Cash From Investing | -$40.7M | -$78.4M | -$70.1M | -$81.6M | -$98.4M | |
Dividends Paid (Ex Special Dividend) | -$16.5M | -$27.7M | -$29.9M | -$32.7M | -$35M | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | -- | -- | -- | -- | -- | |
Long-Term Debt Repaid | -$75.1M | -$121K | -$123K | -$489K | -$663K | |
Repurchase of Common Stock | -$44.2M | -$90.6M | -$5M | -$52.8M | -$77.9M | |
Other Financing Activities | -$14.3M | -- | -- | -- | -- | |
Cash From Financing | -$141.1M | -$144.6M | -$37.1M | -$81.2M | -$102.6M | |
Beginning Cash (CF) | -- | -- | -- | -- | -- | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $128.2M | -$143.9M | $97.9M | -$4.7M | -$13.7M | |
Ending Cash (CF) | -- | -- | -- | -- | -- | |
Levered Free Cash Flow | $272M | $2.4M | $136.4M | $104.6M | $113M |
Period Ending | 2022-04-30 | 2023-04-30 | 2024-04-30 | 2025-04-30 | 2026-04-30 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $152.3M | $151.9M | $124.6M | $101M | -- | |
Depreciation & Amoritzation | $112.7M | $116.7M | $124.7M | $123.6M | -- | |
Stock-Based Compensation | $11.9M | $12.5M | $14.4M | $17.4M | -- | |
Change in Accounts Receivable | -$41.8M | $53.7M | -$16.8M | -$1.9M | -- | |
Change in Inventories | -$72M | $32.3M | $19.9M | $12.8M | -- | |
Cash From Operations | $79M | $205.2M | $158.1M | $187.3M | -- | |
Capital Expenditures | $76.6M | $68.8M | $53.6M | $74.3M | -- | |
Cash Acquisitions | -$26.3M | -$16.8M | -$39.4M | -$29.5M | -- | |
Cash From Investing | -$78.4M | -$70.1M | -$81.6M | -$98.4M | -- | |
Dividends Paid (Ex Special Dividend) | -$27.7M | -$29.9M | -$32.7M | -$35M | -- | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | -- | -- | -- | -- | -- | |
Long-Term Debt Repaid | -$121K | -$123K | -$489K | -$663K | -- | |
Repurchase of Common Stock | -$90.6M | -$5M | -$52.8M | -$77.9M | -- | |
Other Financing Activities | -$24.3M | -$5M | -$6.2M | -$1.4M | -- | |
Cash From Financing | -$144.6M | -$37.1M | -$81.2M | -$102.6M | -- | |
Beginning Cash (CF) | $1.3B | $982.2M | $1.4B | $1.3B | -- | |
Foreign Exchange Rate Adjustment | -$1.9M | -$86K | -$926K | $1.1M | -- | |
Additions / Reductions | -$143.9M | $97.9M | -$4.7M | -$13.7M | -- | |
Ending Cash (CF) | $1.1B | $1.1B | $1.3B | $1.3B | -- | |
Levered Free Cash Flow | $2.4M | $136.4M | $104.6M | $113M | -- |
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.